Bristol Myers Squibb expands radiopharmaceutical pipeline through RayzeBio–Philochem Partnership
The agreement grants RayzeBio exclusive worldwide rights to Philochem’s clinical-stage radiopharmaceutical candidate OncoACP3.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.